Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC
IntroductionTo assess the efficacy of progression-directed radiation therapy (PDRT) in patients with oligoprogressive non-small cell lung cancer (NSCLC), with particular focus on disease progression and changes in systemic therapy.Materials and methodsFrom January 2020 to October 2025, a retrospecti...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-05-01
|
| Serie: | Frontiers in Oncology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1766544/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
